The topic for this debate is ”Given The Chasm Of Scientific Comprehension Between The Public And The Scientific Community Is So Vast, There Is No Such Thing As "Voluntary and Informed Consent" When Planning Human Trials/Experiments."
I will be arguing the PRO position.
_________________________________________________________________
The constitution only gives people the right to pursue happiness, you have to catch it yourself.
Benjamin Franklin
Personal responsibility is one of the cornerstones of American society. As such, whether it comes to politics, one's occupation, personal relationships, and especially as to whether or not to participate in a human clinical trial, the responsibility rests with the participant to get all available information in order to make an informed choice on when deciding whether or not to grant his/her consent.
The American public has many available sources of information:
1. The information provided by those who are conducting the trial.
2. The internet and all it's resources.
3. Their physician.
4. Their Government.
5. The guidelines of "The Declaration of Helsinki" which outlines the ethical standards for human experimentation.
6. The guideline of the NIH defining "informed consent" as:
Informed consent is a continuing process that helps you decide whether to enroll in a trial. During the first meeting and in follow-up meetings the research team will tell you about
tests or treatments that you may get if you are assigned to the treatment group
possible risks and benefits of these tests or treatments
standard tests and treatments available now
what you need to do, such as take medications at a certain time.
NIH
It seems that a plethora of information and protections are readily available and that the responsibility to avail ones self of it rests clearly with the participant.
So what is the problem?
No doubt there are many clinical trials which follow ethical and reputable methods and standards. I will also concede that without those, we would not be benefiting from many of the valuable and life saving treatments and products we use today.
However:
Over the course of this debate I will put before you all the different factors which preclude many participants from making an informed consent. These include but are not limited to, the conductors of the trials:
1. Use of coercive methods.
2. Withholding information.
3. Abusing and taking advantage of the participants' desperation with regards to their medical condition.
4. Conducting knowingly dangerous trials in third world countries which have neither standards nor enforcement.
5. Taking advantage of participants' financial woes.
6. Taking advantage of an FDA which favors business interest above patients' welfare
7. Putting profit before patients.
8. Researchers' desperation to come up with treatments.
There are many other factors which contribute to the deception of participants who grant a consent which is as informed as a reasonable person would expect, but which is in fact often based on lies and deception, leading to serious long term affects and sometimes death for the participants.
Our courtrooms and law journals are littered with such examples of horrific abuse by the conductors of clinical trials. The shocking stories of these clinical trials are regular visitors to front page news. And we are all too familiar with the recurring nature of pharmaceutical recalls such as Vioxx.
These are all well known and documented facts which I believe cannot be contested by my opponent.
And for as long as clinical trials abuses continue in some cases, they will undermine the credibility and validity of all clinical trials.
Informed consent can only be established if everyone involved has done everything they can to make the information available and have acted ethically and with the participants' best interest at hand. Especially when health, life, and death are at stake. Otherwise, consent is worthless. The courts have validated this premise time and again.
Otherwise there would be no need for this:
In an article titled: Regulating Dr. Frankenstein: Money, Lax Ethics, & Clinical Trials, several guidelines are suggested:
In a powerful speech to the NIH (Aug. 16, 2000), Dr. Marcia Angell, the former editor of the New England Journal of Medicine, outlined six things that should be done to remedy the problems typified by the Gelsinger case. In brief, Dr. Angell suggested the adoption of the following guidelines: (1) medical “investigators who receive grant support from industry should have no other financial ties to those companies” (e.g., equity stakes in those companies); (2) “institutions should not accept grants with strings attached. Investigators should design and analyze their own studies, write their own papers and decide about publication”; (3) “consultancy arrangements need to be carefully limited”; (4) “institutions should not become outposts for industry by allowing investor-owned companies to set up teaching or research centers in their hospitals and giving them access to the students, house officers and patients”; (5) “institutions and the senior officials should not have investments in any health care industry”; and (6) “institutions need to get together on this issue and develop a common policy.”
cspinet
[edit on 25-9-2008 by MemoryShock]


No, really…